Wound healing & tissue repair
The CMS-covered indication, backed by closure-rate and new-blood-vessel data across multiple studies.
The body of evidence
Wound and tissue repair is supported by several separate peer-reviewed studies, each of which has its own deep-dive here: new blood-vessel formation (angiogenesis), reduction of sacral pressure ulcers, faster surgical wound closure, and accelerated tendon healing. Together they cover the lab mechanism and the clinical endpoints.
The mechanism behind closure
Angiogenesis — the growth of new blood vessels — is what underpins repair, and the nitric-oxide cascade tPEMF drives is a known stimulus for it. That is why the closure-rate findings in patients track with the laboratory angiogenesis data: same mechanism, measured at two different scales.
Why it carries coverage
Wound healing is where PEMF holds CMS national coverage (NCD 270.1). The evidence collected here is what makes that coverage — and the reimbursement that follows — defensible.
The study design (across the indication)
The wound-healing evidence is drawn from several independent studies rather than a single pivotal trial. Kloth (1999) studied sacral pressure ulcers in paraplegic patients — a defined, high-risk population with a measurable endpoint (ulcer incidence). Strauch (2007) measured surgical wound-closure rates in a clinical setting. Roland (2000) and Weber (2004) quantified angiogenesis in controlled experimental conditions. The convergence of results across different wound types and different study designs strengthens the overall evidence base beyond what any single trial would support.
What this means in practice
A patient with a chronic wound that has failed standard care — dressing changes, debridement, antibiotics — has a Medicare-covered alternative available at home, without a wound-care center visit, using a device that does not touch the wound. The mechanism is angiogenesis: new blood vessels growing into the wound bed, providing the oxygen and growth factor supply that stalled wounds need to restart the repair cycle. For diabetic foot ulcer patients, whose wounds precede the majority of lower-limb amputations, an intervention that accelerates healing has life-altering stakes.
Sources
- Kloth LC, et al. 1999
- Strauch B, et al. 2006, 2007
- Roland 2000; Weber 2004 (angiogenesis)
Related
Ready to put SofPulse to work?
SofPulse is available by prescription. Patients can order online and pay with pre-tax HSA/FSA dollars; clinicians can start prescribing in minutes.
For education only — not medical advice, and not a substitute for a clinician's judgment. SofPulse is available by prescription only. Reimbursement figures reflect the 2026 CMS Physician Fee Schedule and vary by locality, payer, and documentation.